Şunu aradınız:: esperjenzaw (Maltaca - İngilizce)

li esperjenzaw kura
experienced

li esperjenzaw pegifn + rbv
pegifn + rbv experienced

pazjenti adulti li esperjenzaw il-kura
treatment-experienced adult patients

setturi oħra esperjenzaw iktar titjib sinifikanti.
other sectors experienced an even more significant improvement.

bejn 1 kull 10 u 1 kull 100 pazjent esperjenzaw
between 1 in 10 and 1 in 100 patients experience

xi pazjenti esperjenzaw dawn l-effetti sekondarji gravi.
a few patients have experienced these serious side effects.

xi pazjenti esperjenzaw rebound virali bejn Ġimgħa 16 u Ġimgħa 96.
some patients experienced viral rebound between week 16 and week 96.

partikolarrment, xi pazjenti esperjenzaw l-effetti sekondarji li jmiss:
in particular, patients have experienced the following serious side effects:

mid- 908 parteċipanti, 239 minnhom esperjenzaw episodji avversi (aes).
of the 908 participants, 239 thereof experienced adverse events (aes).

l-ebda individwi ma esperjenzaw falliment viroloġiku jew rikaduta waqt il-kura.
no subjects experienced on-treatment virologic failure or relapse.

b’mod partikolari, xi pazjenti esperjenzaw effetti sekondarji serji li ġejjin:
in particular, patients have experienced the following serious side effects:

individwi studjati li esperjenzaw trattament kineu kienu primarjament pegifn + rbv mingħajr rispons.
the treatment-experienced subjects studied were primarily pegifn/rbv null responders.

kien irrapportat li pazjenti maskili esperjenzaw impotenza, sterilità, ażoospermja, u atrofija testikulari.
impotence, sterility, azoospermia, and testicular atrophy have been reported in male patients.

19-il pajjiż esperjenzaw tkabbir għolja mill-medja ta' 8.5%.
19 countries experienced growth above the average of 8.5%.

erbgħa (44%) mid- disa 'pazjenti refrattarji esperjenzaw rispons komplet għal nelarabine.
four (44%) of the nine refractory patients experienced a complete response to nelarabine.

il-pazjenti ma jridux ikunu esperjenzaw falliment ta’ terapija preċedenti kontra l-hiv.
patients must not have experienced failure of a previous hiv therapy.

b’mod globali, 32.2% tal-pazjenti esperjenzaw reazzjonijiet avversi tal-mediċina.
overall 32.2% of the patients experienced adverse drug reactions.

svr12 għal individwi li esperjenzaw peginterferon+ribavirin, infettati bil-ġenotip 1 f’sapphire-ii
svr12 for genotype 1-infected peginterferon+ribavirin-experienced subjects in sapphire-ii

f'ħafna każijiet, id-ditti l-inqas produttivi esperjenzaw tkabbir negattiv fil-produttività.
in many cases, the least productive firms have experienced negative productivity growth.

mill-1,084 pazjent li esperjenzaw disturb viżiv, 95% kellhom avvenimenti li kienu ħfief fis-severità.
of the 1084 patients who experienced vision disorder, 95% had events that were mild in severity.